- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eckert & Ziegler AG O.N. (EUZG)
The Eckert&Ziegler AG share price today is 15.340, view ETR EUZG stock exchange data. Track the latest Eckert&Ziegler AG share price with real-time updates on EUZG stock performance including market cap, day range, 52-week range and dividend yield. Access EUZG charts, earnings dates and analyst estimates to support your investment decisions.
15.340
+0.840(+5.79%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.390
15.710
52 wk Range
11.910
16.840
EUZG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.39015.710
52 wk Range
11.91016.840
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EUZG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
21.933
Upside
+42.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Germany shares mixed at close of trade; DAX up 0.57%- Investing.com
- Germany shares mixed at close of trade; DAX up 0.57%
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 21.933
(+42.98% Upside)
Earnings
Latest Release
12-11-2026
EPS / Forecast
0.21 / --
Revenue / Forecast
78.8M / --
Compare EUZG to Peers and Sector
Metrics to compare | EUZG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEUZGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.1x | 15.3x | −0.2x | |
PEG Ratio | 0.46 | 0.30 | 0.00 | |
Price/Book | 3.5x | 2.4x | 2.6x | |
Price / LTM Sales | 3.0x | 1.6x | 2.8x | |
Upside (Analyst Target) | 43.0% | 48.1% | 65.0% | |
Fair Value Upside | Unlock | 16.4% | 9.6% | Unlock |
Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Eckert&Ziegler AG (EUZG) Share Price Today?
The Eckert&Ziegler AG share price today is 15.340.
What is the current Eckert&Ziegler AG (EUZG) share price and day range?
As of 14-11-2026, the Eckert&Ziegler AG share price is 15.340, with a previous close of 15.340. The share price has ranged from 14.390 to 15.710 today, while the 52-week range spans from 11.910 to 16.840.
What Is the Eckert&Ziegler AG Market Cap?
As of today, Eckert&Ziegler AG market cap is 959.920M.
Does Eckert&Ziegler AG Pay Dividends? What's The Current Dividend Yield?
The Eckert&Ziegler AG dividend yield is 1.4%%.
What Is the Eckert&Ziegler AG (EUZG) Share Price Target?
The average 12-month share price target for Eckert&Ziegler AG is 21.933, with a high estimate of 24 and a low estimate of 20.3. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +42.98% Upside potential.
What Is Eckert&Ziegler AG's Earnings Per Share (TTM)?
The Eckert&Ziegler AG EPS (TTM) is 0.87.
From a Technical Analysis Perspective, Is EUZG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Eckert&Ziegler AG Trade On?
Eckert&Ziegler AG is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for Eckert&Ziegler AG?
The stock symbol for Eckert&Ziegler AG is "EUZG."
How Many Times Has Eckert&Ziegler AG Stock Split?
Eckert&Ziegler AG has split 4 times.
How Many Employees Does Eckert&Ziegler AG Have?
Eckert&Ziegler AG has 1105 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.